CancerTherapyAdvisor
@CancerTherAdvsr
http://CancerTherapyAdvisor.com is a resource offering oncology health care professionals practical information about the changing clinical landscape.
#Childhoodcancer survivors have a higher risk of developing severe #COVID19 than the general population. Published in @LancetRH_Europe. bit.ly/46F7GR5 #COVID19nCancer
New data suggest that #breastfeeding is safe for patients with stage I-III #breastcancer who have HR-positive disease or carry BRCA variants. From @JCO_ASCO and @JNCI_Now. bit.ly/4lZDEwB #bcsm
The Trump administration’s immigration policies are having negative effects on #healthcare, impacting patients and health care workers alike. Interviews with Dr Leighton Ku of @GWtweets, Dr Katherine Peeler of @BostonChildrens & @harvardmed, and @swoolhandler of @Hunter_College.…
Cuts to #Medicaid prompted by the #OneBigBeautifulBillAct could lead to thousands of excess deaths, hundreds of thousands of preventable hospitalizations, and billions of dollars in economic losses. Published in @JAMAHealthForum. bit.ly/40ww3g5
The prices charged at the US launch of targeted #cancer therapies have increased well above the rate of inflation every year since 2012. Published in @JAMA_current and @CancerTherAdvsr. bit.ly/4lRtzky
Chemotherapy can increase mutation burden and change the cell population structure of normal blood, which contributes to long-term #adverseEffects such as second malignancies and infertility, according to researchers. Reported in @NatureGenet and @CancerTherAdvsr.…
Searching for the latest news and research about general oncology? Sign up for the Grand Roundup, our curated newsletter to help you stay informed on clinical topics that matter most to you: bit.ly/4jYkuFw

Updated results from the phase 3 BELLINI trial suggest that adding venetoclax to treatment with bortezomib and dexamethasone does not improve OS in patients with R/R #multiplemyeloma. Published in @TheLancetHaem. bit.ly/464u1aH #mmsm
Serial high-sensitivity troponin I measurements may help predict death from any cause in #cancer patients treated with ICIs. Published in @OncJournal. bit.ly/46tzKHa
Sign up today for our bi-weekly email covering emerging research, conference news, and guideline updates on general oncology, breast cancer and lung cancer: bit.ly/4jYkuFw

New research suggests that patients with certain advanced #cancers have experienced improvements in survival since ICIs entered the market, but patients without #healthinsurance have not derived the same benefits as patients with private insurance. Published in @JAMANetworkOpen.…
Adding metformin to standard care for #mHSPC does not improve survival outcomes overall but may improve some outcomes in patients with high-volume disease. Published in @TheLancetOncol. bit.ly/4lxRgyO #prostatecancer #pcsm
Obesity-related #cancer deaths increased nearly 6% per year, on average, from 1999 to 2020, according to results of a study presented at #ENDO2025. shorturl.at/YRHSW #ENDO25
Patients with locally advanced #rectalcancer receive a variety of TNT regimens in clinical practice, but the regimens are similarly effective. Published in @JAMAOnc. bit.ly/4kEwX18 #gicsm
Adolescents with #cancer and their parents believe parents should have access to non-sensitive clinical data in patient portals. Published in @JCOCCI_ASCO. bit.ly/4lry1Xp #PedOnc
Invikafusp alfa, a dual T-cell agonist targeting subsets of tumor-infiltrating lymphocytes, can elicit responses in patients with heavily pretreated gastrointestinal cancers. Presented at @myESMO conference #ESMOGI25. bit.ly/4eAxhg6 #gicsm
Looking for a curated list of the top news and updates on lung cancer? Sign up for the Grand Roundup newsletter, delivered to your inbox bi-weekly. bit.ly/4jYkuFw

#Breastcancer patients may have inferior recurrence-free survival after neoadjuvant chemotherapy if they are overweight or obese at diagnosis, researchers report. From @CBCjournal. bit.ly/3Ii0alh #bcsm
#Uterinecancer cases and deaths are projected to increase “substantially” in Black women and White women in the US, according to researchers. From @CEBP_AACR. bit.ly/4ksHY5M #gyncsm
CtDNA testing after surgery can be used to predict RFS and OS in patients with #NSCLC. From @ClinOncology. bit.ly/4ktrlXw #lcsm